SENTELYS PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SENTELYS PHARMA
Largest movements
- Financial fixed assets +€26,628
up €26,628 (+14.8%), from €180,000 to €206,628
- Cash -€20,736
down €20,736 (-87.0%), from €23,822 to €3,085
mainly Investment in fixed assets (net) (-€26,628) and Debts after one year (-€16,273)
- Receivables within one year +€13,525
up €13,525 (+3,354%), from €403 to €13,928
of which Other amounts receivable: +€12,815
- Other debts +€51,671
up €51,671 (+3,842%), from €1,345 to €53,016
- Debts after one year -€16,273
down €16,273 (-9.9%), from €164,469 to €148,196
- Profit (loss) carried forward -€13,094
down €13,094 (-116%), from -€11,296 to -€24,391
- Tax, wage and social debts -€2,469
down €2,469 (-45.6%), from €5,409 to €2,940
- Financial charges +€10,316
up €10,316 (+604%), from €1,709 to €12,025
- Gross operating margin +€9,409
up €9,409 (+98.3%), from -€9,571 to -€163
- Taxes +€669
up €669 (+4,134%), from €16 to €685
- Other operating charges +€224
new in 2025: €224
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €205,837 | €225,328 | +€19,491 | +9.5% |
| Fixed assets | 21/28 | €180,000 | €206,628 | +€26,628 | +14.8% |
| Financial fixed assets | 28 | €180,000 | €206,628 | +€26,628 | +14.8% |
| Current assets | 29/58 | €25,837 | €18,700 | -€7,137 | -27.6% |
| Amounts receivable within one year | 40/41 | €403 | €13,928 | +€13,525 | +3,354% |
| Trade receivables | 40 | €403 | €1,113 | +€710 | +176% |
| Other amounts receivable | 41 | - | €12,815 | +€12,815 | |
| Cash at bank and in hand | 54/58 | €23,822 | €3,085 | -€20,736 | -87.0% |
| Deferred charges and accrued income | 490/1 | €1,612 | €1,687 | +€75 | +4.7% |
| Total equity and liabilities | 10/49 | €205,837 | €225,328 | +€19,491 | +9.5% |
| Equity | 10/15 | €13,704 | €609 | -€13,094 | -95.6% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€11,296 | -€24,391 | -€13,094 | -116% |
| Amounts payable | 17/49 | €192,133 | €224,718 | +€32,585 | +17.0% |
| Amounts payable after more than one year | 17 | €164,469 | €148,196 | -€16,273 | -9.9% |
| Financial debts | 170/4 | €164,469 | €148,196 | -€16,273 | -9.9% |
| Amounts payable within one year | 42/48 | €27,098 | €76,005 | +€48,907 | +180% |
| Current portion of amounts payable after more than one year | 42 | €16,978 | €17,602 | +€625 | +3.7% |
| Trade debts | 44 | €3,367 | €2,447 | -€920 | -27.3% |
| Suppliers | 440/4 | €3,367 | €2,447 | -€920 | -27.3% |
| Taxes, remuneration and social security | 45 | €5,409 | €2,940 | -€2,469 | -45.6% |
| Taxes | 450/3 | €5,409 | €2,940 | -€2,469 | -45.6% |
| Other amounts payable | 47/48 | €1,345 | €53,016 | +€51,671 | +3,842% |
| Accrued charges and deferred income | 492/3 | €566 | €517 | -€49 | -8.6% |
| Other operating charges | 640/8 | - | €224 | +€224 | |
| Gross operating margin | 9900 | -€9,571 | -€163 | +€9,409 | +98.3% |
| Operating profit (loss) | 9901 | -€9,571 | -€387 | +€9,184 | +96.0% |
| Financial income | 75/76B | - | €3 | +€3 | |
| Recurring financial income | 75 | - | €3 | +€3 | |
| Financial charges | 65/66B | €1,709 | €12,025 | +€10,316 | +604% |
| Recurring financial charges | 65 | €1,709 | €12,025 | +€10,316 | +604% |
| Profit (loss) for the period before taxes | 9903 | -€11,280 | -€12,409 | -€1,129 | -10.0% |
| Income taxes | 67/77 | €16 | €685 | +€669 | +4,134% |
| Profit (loss) for the period | 9904 | -€11,296 | -€13,094 | -€1,798 | -15.9% |
| Profit (loss) for the period to be appropriated | 9905 | -€11,296 | -€13,094 | -€1,798 | -15.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.